8

Nearly one in three Europeans has experimented with illegal drugs, with patterns of use varying widely from country to country. In 2024, data from the European Commission and the OECD revealed that 15% of young adults in the European Union reported using cannabis, while 2.5% admitted to using cocaine. These substances continue to dominate the landscape of illegal drug use, although new trends and emerging drugs are presenting additional challenges for European countries.

Cannabis: Widespread but Uneven Use

Cannabis remains the most commonly used illegal drug across Europe, with varying usage rates depending on the country. In nations like the Czech Republic, Italy, France, and Spain, cannabis consumption is particularly high. These countries report some of the highest usage rates among young adults, reflecting a more liberal stance on cannabis or perhaps higher availability. On the other hand, countries such as Malta, Turkey, and Hungary report the lowest rates of cannabis use, which may be attributed to stricter laws or cultural differences.

Despite stringent drug policies in some nations, the availability of cannabis remains high, especially among younger populations. Sabrina Molinaro, an epidemiologist at Italy’s National Research Council, noted that “harsh penalties often target casual users instead of addressing the heavy consumers.” This observation underscores the challenge for governments in creating drug policies that effectively tackle the root causes of addiction and misuse.

Molinaro’s research, which has focused on 16-year-olds across Europe, reveals that the trends in cannabis use have remained relatively stable over the years. However, a shift is becoming apparent: the gender gap in cannabis use is narrowing. Historically, boys used cannabis more frequently, but recent data shows that in some regions, girls are now surpassing boys in terms of usage. This change suggests that cultural and social factors are increasingly influencing drug consumption patterns.

Cocaine: A Growing Concern

Cocaine, the second most commonly used illegal drug in Europe, is seeing an uptick in usage, particularly in certain countries. According to the latest data, cocaine use is most prevalent in the Netherlands, Spain, and Ireland. These nations have high consumption rates, driven in part by urban centers with greater access to the drug. In contrast, countries like Turkey, Portugal, Poland, and Hungary report lower usage rates, though this may be linked to stricter enforcement and less availability.

Cocaine use is often linked to higher risks, including mental health issues, heart problems, and addiction. The growing consumption of cocaine presents challenges for public health authorities, who must balance law enforcement with health-based interventions to address the broader societal impacts.

The Rise of Synthetic Drugs

While cannabis and cocaine continue to dominate, synthetic drugs are becoming a major concern for health experts and law enforcement agencies across Europe. These drugs, which include MDMA (ecstasy), heroin, opioids, and various psychedelics, are gaining traction due to their cheap production costs and high potency. Synthetic drugs are particularly dangerous because they are often produced in unregulated labs, leading to inconsistencies in composition and potential contamination.

Sabrina Molinaro warns that “synthetic drugs are particularly dangerous because users often don’t know what they’re consuming.” Unlike natural drugs, which have a more predictable composition, synthetic substances are manufactured with little oversight. This unpredictability increases the risk of overdose and other health complications. In 2022, hundreds of synthetic drug labs were dismantled across the European Union, but this did not slow the production or distribution of these dangerous substances.

In 2023, authorities detected seven new synthetic opioid compounds that are highly potent and hazardous to users. These synthetic opioids are often stronger than traditional opioids like heroin, making them a significant risk factor for overdose deaths. Law enforcement agencies are struggling to keep up with the constantly evolving landscape of synthetic drugs, which are frequently designed to circumvent existing drug laws.

Public Health Risks and Policy Gaps

Frequent drug use, particularly of substances like cannabis, cocaine, and synthetic drugs, is associated with a wide range of health risks. These include cardiovascular diseases, mental health issues like anxiety and depression, and an increased risk of accidents. Injecting drugs, such as heroin or opioids, also raises the likelihood of spreading infectious diseases like HIV and hepatitis, which further complicates public health efforts.

The rapid emergence of new synthetic substances adds another layer of complexity to the situation. These drugs are difficult to track, and their unpredictable effects make it harder for health experts to advise the public on potential dangers. The existing regulatory frameworks in many European countries have struggled to keep pace with the speed at which new drugs are introduced to the market.

“This is a pressing public health concern,” says Molinaro. European policymakers must act swiftly to address these growing threats. Molinaro advocates for policies that prioritize prevention and early intervention. Governments must also be able to adapt their regulations in real time to respond to new and emerging drug risks.

Addressing the Drug Epidemic

To effectively combat the rise in drug use, especially among young people, European governments need to take a more proactive approach. This includes better education programs, improved access to treatment services, and a more flexible regulatory framework that can adapt to the constantly changing drug landscape.

Molinaro suggests that policymakers focus on preventing drug use before it starts. This could involve investing in educational campaigns that raise awareness of the risks associated with drug consumption. Additionally, offering treatment and rehabilitation services for individuals struggling with addiction will help reduce the long-term societal costs of drug abuse.

One key area where many countries are failing is in providing adequate support for individuals dealing with addiction. While some nations have made strides in offering harm reduction strategies, many others still focus predominantly on punitive measures, such as imprisonment for drug users. This approach often fails to address the root causes of addiction, such as mental health issues, poverty, and social isolation.

Ultimately, a balanced approach that combines law enforcement, public health initiatives, and social support systems is essential in tackling Europe’s growing drug problem.

For more updates and in-depth coverage of drug trends in Europe, visit Financial Mirror.